Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health
Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health
www.georgeinstitute.org.au Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
![Why low-cost ketamine is still inaccessible to many with severe depression | The George Institute for Global Health](https://lemmy.world/pictrs/image/562dc2bf-690a-45de-b064-66b3c2b21d06.jpeg?format=webp&thumbnail=256)
You're viewing a single thread.
All Comments
1 comments